blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0898963

EP0898963 - Congestive heart failure treatment [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.07.2008
Database last updated on 02.11.2024
Most recent event   Tooltip18.07.2008Application deemed to be withdrawnpublished on 20.08.2008  [2008/34]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1999/09]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Kauffman, Raymond Francis
11420 Saint Andrews Lane
Carmel, Indiana 46032 / US
02 / Palkowitz, Alan David
10737 Kingsmill Drive
Carmel, Indiana 46032 / US
[1999/09]
Representative(s)Burnside, Ivan John
Eli Lilly and Company Limited
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU / GB
[N/P]
Former [2004/10]Burnside, Ivan John
Eli Lilly and Company Limited Lilly Research Centre Erl Wood Manor
Windlesham, Surrey GU20 6PH / GB
Former [1999/09]Denholm, Anna Marie
Eli Lilly and Company Limited, Lilly Research Center, Erl Wood Manor
Windlesham, Surrey GU20 6PH / GB
Application number, filing date98306621.818.08.1998
[1999/09]
Priority number, dateUS19970056135P19.08.1997         Original published format: US 56135 P
[1999/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0898963
Date:03.03.1999
Language:EN
[1999/09]
Type: A3 Search report 
No.:EP0898963
Date:09.07.2003
[2003/28]
Search report(s)(Supplementary) European search report - dispatched on:EP20.05.2003
ClassificationIPC:A61K31/00, A61K31/40, A61K31/415, A61K31/445, A61K31/42, A01K67/027
[2003/12]
CPC:
A61K31/535 (EP); A61K31/00 (EP); A61K31/495 (EP);
A61K31/54 (EP); A61P9/00 (EP)
Former IPC [1999/09]A61K31/00, A61K31/415, A61K31/40, A61K31/445
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2004/14]
Former [1999/09]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
Extension statesAL29.08.1998
LT29.08.1998
LV29.08.1998
RO29.08.1998
SI29.08.1998
TitleGerman:Behandlung des kongestiven Herzversagens[1999/09]
English:Congestive heart failure treatment[1999/09]
French:Traitement de l'insuffisance cardiaque congestive[1999/09]
Examination procedure29.08.1998Examination requested  [1999/09]
15.10.2007Despatch of a communication from the examining division (Time limit: M04)
26.02.2008Application deemed to be withdrawn, date of legal effect  [2008/34]
02.04.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/34]
Fees paidRenewal fee
07.08.2000Renewal fee patent year 03
06.08.2001Renewal fee patent year 04
07.08.2002Renewal fee patent year 05
06.08.2003Renewal fee patent year 06
06.08.2004Renewal fee patent year 07
08.08.2005Renewal fee patent year 08
07.08.2006Renewal fee patent year 09
03.08.2007Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9724369  (PFIZER [US], et al) [X] 1,2,10-12,14 * page 4, line 5 - page 8, line 23 * * page 28, line 25 - page 29, line 3 * * page 30, line 8 - line 26 * * page 36, line 11 - line 12 * * page 36, line 29 - page 37, line 3 * * page 37, line 11 - line 23 * * claims 1,49,50,103 *;
 [PX]WO9822124  (PHARMACIA & UPJOHN AB [SE], et al) [PX] 1,2,10,11,14 * page 26, line 2 - line 8; claims 1,2,12-15 *;
 [A]WO9615148  (GENENTECH INC [US]) [A] 1-3,11 * page 4, line 16 - page 9, line 36 * * claims 1-3,15,17-20 *;
 [AD]WO9413696  (MERCK & CO INC [US], et al) [AD] 1-3,10,11,14 * claims 1,10-12 *;
 [A]US5492916  (MORRIELLO GREGORI J [US], et al) [A] 1-3,10,11,14 * claim - *;
 [AD]US5206235  (FISHER MICHAEL H [US], et al) [AD] 1-3,10,11,14 * example -; claims 1,7,8 *;
 [A]EP0761220  (LILLY CO ELI [US]) [A] 1-3 * examples 8,9,11,13-17; claims 1,7,8 *;
 [AD]WO9304081  (UNIV TULANE [US]) [AD] 2 * page 7, lines 6 to 4 from the bottom *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.